Press Releases Zentiva S.A.

Equities

End-of-day quote Bucharest S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
3.26 ^RON	+0.62%		+1.24%	+11.64%

Apr. 01	Biocon Limited, Through Zentiva, Receives Approval from, U.K., for its Complex Formulation Liraglutide (gSaxenda®) in 6mg/ml Solution	CI
Feb. 29	Zentiva S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Zentiva S A : SCD_Zentiva_Annual Report 2023-EN	Apr. 30	PU
Biocon is the first generics company to obtain approval for diabetes drug, Liraglutide, in the U.K.	Mar. 28	AQ
Zentiva S A : Convening notice Zentiva S.A. – OGMS and EGMS_29.04.2024	Mar. 27	PU
Zentiva S A : Memo_Substantiation note_OGMS_29.04.2024	Mar. 27	PU
Zentiva S A : Draft Resolution_OGMS_29.04.2024	Mar. 27	PU
Zentiva S A : SCD_Zentiva_Fin report 30.06.2023-EN	23-08-31	PU
Zentiva S A : SCD_Zentiva_Fin report 31.03.2023-EN	23-05-15	PU
STEFFEN SALTOFTE APPOINTED AS CEO OF ZENTIVA	23-04-19	AQ
Zentiva S A : Memo_Substantiation note_OGMS_27.04.2023	23-03-27	PU
Zentiva S A : Draft Resolution_OGMS_27.04.2023	23-03-27	PU
Zentiva S A : Auditor’s Report_31.12.2022	23-03-27	PU
Zentiva S A : Annual remuneration report for the management of Zentiva SA_2022	23-03-27	PU
Zentiva S A : Remuneration policy for the management of Zentiva_draft	23-03-27	PU
Zentiva S A : Memo_Substantiation note_EGMS_27.04.2023	23-03-27	PU
Zentiva S A : Draft Resolution_EGMS_27.04.2023	23-03-27	PU
Zentiva S A : SCD_Zentiva_Preliminary financial report_31.12.2022_EN	23-02-28	PU
The number of promising young scientists is increasing, Zentiva has awarded them for the fifth time	23-02-28	AQ
Zentiva S A : Memo_Substantiation note_OGMS_20.03.2023	23-02-15	PU
Zentiva S A : Draft Resolution_OGMS_20.03.2023	23-02-15	PU
Zentiva S A : GDPR Disclaimer_EN	23-02-15	PU

No results for this search